1.75
price down icon6.42%   -0.12
 
loading

Finanzdaten der Equillium Inc-Aktie (EQ)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 4.392 12.16 13.85
Operating Expenses
29.79%
6.228
8.87 9.09 12.84 13.95
Operating Income/Loss
29.79%
-6.228
-8.87 -4.698 -0.679 -0.10
Income/Loss From Continuing Operations Before Tax
33.68%
-5.739
-8.654 -5.433 12.16 0.468
Income Tax Expense/Benefit
-
- 0.361 - -
Income/Loss From Continuing Operations After Tax
33.68%
-5.739
-8.654 -5.794 -0.007 0.468
Net Income/Loss
33.68%
-5.739
-8.654 -5.794 -0.007 0.468
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.37%
35.72
35.59 0.0335 35.42 35.29
Diluted Average Shares
0.37%
35.72
35.59 0.0335 35.42 36.59
Basic Earnings Per Share
33.33%
-0.16
-0.24 -0.17 - 0.01
Diluted Earnings Per Share
33.33%
-0.16
-0.24 -0.17 - 0.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):